Follow
Carmine Marco Morgillo
Title
Cited by
Cited by
Year
Exploitation of a very small peptide nucleic acid as a new inhibitor of miR‐509‐3p involved in the regulation of cystic fibrosis disease‐gene expression
F Amato, R Tomaiuolo, F Nici, N Borbone, A Elce, B Catalanotti, ...
BioMed research international 2014 (1), 610718, 2014
532014
Peptide nucleic acids as miRNA target protectors for the treatment of cystic fibrosis
F Zarrilli, F Amato, CM Morgillo, B Pinto, G Santarpia, N Borbone, ...
Molecules 22 (7), 1144, 2017
412017
Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode
J Karlsson, CM Morgillo, A Deplano, G Smaldone, E Pedone, FJ Luque, ...
PLoS One 10 (11), e0142711, 2015
182015
Identification of a proteasome-targeting arylsulfonamide with potential for the treatment of Chagas’ disease
ML Lima, LB Tulloch, V Corpas-Lopez, S Carvalho, RJ Wall, R Milne, ...
Antimicrobial agents and chemotherapy 66 (1), e01535-21, 2022
112022
Novel propanamides as fatty acid amide hydrolase inhibitors
A Deplano, CM Morgillo, M Demurtas, E Bj÷rklund, M Cipriano, ...
European Journal of Medicinal Chemistry 136, 523-542, 2017
112017
Structural Model of the hUbA1-UbcH10 Quaternary Complex: In Silico and Experimental Analysis of the Protein-Protein Interactions between E1, E2 and Ubiquitin
S Correale, I de Paola, CM Morgillo, A Federico, L Zaccaro, P Pallante, ...
Plos one 9 (11), e112082, 2014
112014
Design, synthesis and inávitro and inávivo biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potentialá…
A Deplano, J Karlsson, F Moraca, M Svensson, C Cristiano, CM Morgillo, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 940-953, 2021
52021
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition
CM Morgillo, A Lupia, A Deplano, L Pirone, B Fiorillo, E Pedone, ...
International Journal of Molecular Sciences 23 (24), 15502, 2022
12022
Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation
AP Falanga, A Lupia, L Tripodi, CM Morgillo, F Moraca, GN Roviello, ...
Heliyon 10 (3), 2024
2024
Design and pharmacological evaluation of Ibuprofen amides derivatives as dual FAAH/COX inhibitors
F Moraca, C Morgillo, A Deplano, E Novellino, V Onnis, C Fowler, ...
Design and pharmacological evaluation of Ibuprofen amides derivatives asá…, 2019
2019
Target Protector PNA: a new tool in Cystic Fibrosis treatment
B Pinto, G Oliviero, N Borbone, S D’Errico, F Nici, G Santarpia, C Morgillo, ...
2016
Discovery of a novel class of profen derivatives as FAAH inhibitors: MD and QM/MM studies of the binding mode and 3D SAR
CM Morgillo, A Deplano, J Karlsson, M Svensson, A Bj÷rklund, CJ Fowler, ...
EuroQSAR 2016 Abstract Book, 2016
2016
Investigation of the mechanism of FAAH inhibition of profen amide derivatives
C Morgillo, A Deplano, M Demurtas, J Karlosson, V Onnis, C Congiu, ...
XXIII National Meeting on Medicinal Chemistry Abstract Book, 95-95, 2015
2015
DESIGN, SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NEW FAAH INHIBITORS
V Onnis, C Congiu, A Deplano, M Demurtas, M Cipriano, CJ Fowler, ...
CHEMMEDCHEM, 429-429, 2014
2014
Homology building, protein-protein docking and MD approach to the simulation of the quaternary complex E1/E2/Ub2
CM Morgillo, E Stendardo, A Galeone, B Catalanotti
2012
From protein-protein interaction to E2 inhibitors leads: identification of peptide binding of UbcH10
CM Morgillo, S Correale, A Federico, I DE PAOLA, F Forti, L Zaccaro, ...
2012
The system can't perform the operation now. Try again later.
Articles 1–16